TNFSF4 and neoplasm: Overall, we observed that OX40L/PPT treatment successfully inhibited tumor growth in B16F0 and CT26gfp tumor models and showed a tendency to inhibit 4T1 tumor growth, though the extent of this inhibition could be improved.